Multicentre, Open-label, Randomised Study to Assess the Diagnostic Value of Amyloid PET Imaging in Patients with Subjective Cognitive Decline Plus, Mild Cognitive Impairment, or Dementia Where Alzheimer's Disease is in the Differential Diagnosis
Latest Information Update: 01 Apr 2024
At a glance
- Drugs Florbetaben F18 (Primary) ; Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms DPMS
Most Recent Events
- 30 Mar 2024 This study has been Completed in Germany, According to European Clinical Trials Database record.
- 26 Jun 2018 New trial record